Search results
Results from the WOW.Com Content Network
In May 2016 Biogen announced that it would spin off its hemophilia drug business (Eloctate and Alprolix) into a separate public company. [5] In August, Biogen announced they would call the spun off company Bioverativ to show heritage with Biogen, [6] and would be spun off in early 2017. [7]
In 2022, Louis Vuitton announced a €1 million donation to UNICEF to help the Ukrainian victims of the Russian invasion. [107] On 2 March 2022, LVMH Group pledged €5 million to the Red Cross to those affected by the war. [108] [109] In addition, the company closed 124 of its stores in Russia. [110]
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
The Daniel M. Dickinson Stock Index From January 2008 to December 2012, if you bought shares in companies when Daniel M. Dickinson joined the board, and sold them when he left, you would have a 23.5 percent return on your investment, compared to a -2.8 percent return from the S&P 500.
The Anthony F. Earley, Jr. Stock Index From March 2009 to December 2012, if you bought shares in companies when Anthony F. Earley, Jr. joined the board, and sold them when he left, you would have a 369.9 percent return on your investment, compared to a 85.6 percent return from the S&P 500.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
The former Brussels Stock Exchange building. The BEL 20 is the benchmark stock market index of Euronext Brussels. It tracks the performance of 20 most capitalized and liquid stocks traded in Belgium. In general, the index consists of a minimum of 10 and a maximum of 20 companies traded at the Brussels Stock Exchange.